Medifast
Medifast
MED
NYSE
14.03
USD
-0.14%
About
Medifast, Inc. is a health and wellness company. The Company provides a habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a comprehensive approach to help them achieve lasting optimal health and wellbeing. OPTAVIA's lifestyle plans deliver clinically proven health benefits as well as evidence-based tools, including scientifically developed products and a framework for habit creation reinforced by independent coaches and community support.
Through a collaboration with the virtual primary care provider LifeMD, Inc (LifeMD), OPTAVIA customers have access to board-certified affiliated clinicians and medications, such as GLP-1s, that support treatment plans for obesity and other health conditions. OPTAVIA Coaches introduce customers to a set of healthy habits, and offer OPTAVIA-branded products, including Fuelings as well as OPTAVIA ACTIVE, a line of essential amino acid supplements and protein powders.
Its operations are conducted through its subsidiaries..
Financials Amount (in millions)
Income statement
Balance sheet
Cash flow
Ratios
| Price and Volume | |
|---|---|
| Volume | |
| Ten Day Average Volume | 242.3K |
| Three Month Average Volume | 10.5M |
| High Low | |
| Fifty-Two Week High | 85.62 USD |
| Fifty-Two Week Low | 17.86 USD |
| Fifty-Two Week High Date | 01 Sep 2023 |
| Fifty-Two Week Low Date | 22 Jul 2024 |
| Price and Volume | |
| Current Price | 18.3 USD |
| Beta | 1 |
| Relative Price Change | |
| Four Week Relative Price Change | -19.32% |
| Thirteen Week Relative Price Change | -33.57% |
| Twenty-Six Week Relative Price Change | -58.84% |
| Fifty-Two Week Relative Price Change | -82.68% |
| Year-to-Date Relative Price Change | -77.01% |
| Price Change | |
| One Day Price Change | -1.61% |
| Thirteen Week Price Change | -28.90% |
| Twenty-Six Week Price Change | -54.75% |
| Five Day Price Change | -8.41% |
| Fifty-Two Week Price Change | -78.30% |
| Year-to-Date Price Change | -72.78% |
| Month-to-Date Price Change | -16.55% |
| Per Share Data | |
|---|---|
| Book Value | |
| Book Value Per Share (Last Fiscal Year) | 18.49128 USD |
| Book Value Per Share (Most Recent Quarter) | 18.76959 USD |
| Tangible Book Value Per Share (Last Fiscal Year) | 18.49128 USD |
| Tangible Book Value Per Share (Most Recent Quarter) | 18.76959 USD |
| EBITD | |
| EBITD Per Share (Trailing Twelve Months) | 4.3297 USD |
| Revenue | |
| Revenue Per Share (Last Fiscal Year) | 98.16445 USD |
| Revenue Per Share (Trailing Twelve Months) | 70.43748 USD |
| Dividend | |
| Dividend Per Share (Last Fiscal Year) | 4.95 USD |
| Dividend Per Share (Trailing Twelve Months) | 1.65 USD |
| Dividend Per Share (5 Year) | 5.018 USD |
| Earnings Per Share | |
| Excluding Extraordinary Items (Last Fiscal Year) | 9.1031 USD |
| Excluding Extraordinary Items (Trailing Twelve Months) | 2.68227 USD |
| Normalized (Last Fiscal Year) | 9.1031 USD |
| Basic Excluding Extraordinary Items (Last Fiscal Year) | 9.13405 USD |
| Basic Excluding Extraordinary Items (Trailing Twelve Months) | 2.69447 USD |
| Including Extraordinary Items (Last Fiscal Year) | 9.1031 USD |
| Including Extraordinary Items (Trailing Twelve Months) | 2.68227 USD |
| Cash | |
| Cash Per Share (Last Fiscal Year) | 13.77028 USD |
| Cash Per Share (Most Recent Quarter) | 14.94971 USD |
| Cash Flow Per Share (Last Fiscal Year) | 10.30327 USD |
| Cash Flow Per Share (Trailing Twelve Months) | 3.87964 USD |
| Free Cash Flow Per Share (Trailing Twelve Months) | 1.61557 USD |
| Margins | |
|---|---|
| Cash Flow Revenue | |
| Cash Flow Revenue (5 Year) | 5 |
| Cash Flow Revenue (Trailing Twelve Months) | 2 |
| Pretax Margin | |
| Pretax Margin (Trailing Twelve Months) | 4.84% |
| Pretax Margin (Last Fiscal Year) | 12.01% |
| Pretax Margin (5 Year) | 12.93% |
| Gross Margin | |
| Gross Margin (Last Fiscal Year) | 72.37% |
| Gross Margin (Trailing Twelve Months) | 73.94% |
| Gross Margin (5 Year) | 73.20% |
| Operating Margin | |
| Operating Margin (Last Fiscal Year) | 11.79% |
| Operating Margin (Trailing Twelve Months) | 4.45% |
| Operating Margin (5 Year) | 12.88% |
| Net Profit Margin | |
| Net Profit Margin (Last Fiscal Year) | 9.27% |
| Net Profit Margin (Trailing Twelve Months) | 3.81% |
| Net Profit Margin (5 Year) | 10.06% |
| Growth | |
|---|---|
| Book Value | |
| Book Value Per Share (5 Year) | 15.00% |
| Tangible Book Value (5 Year) | 13.05% |
| Free Operating Cash Flow | |
| Free Operating Cash Flow (5 Year) | 15.81% |
| Revenue | |
| Revenue Change MRQ vs 1 Year Ago | -43.09% |
| Revenue Growth (3 Year) | 16.43% |
| Revenue Change (Trailing Twelve Months) | -43.90% |
| Revenue Per Share Growth | 18.80% |
| Revenue Growth (5 Year) | 4.67% |
| Capital Spending Debt | |
| Capital Spending (5 Year) | 5.59% |
| Total Debt (5 Year) | -99,999.99% |
| Dividends | |
| Dividend Growth (3 Year) | 3.08% |
| Earnings Per Share | |
| EPS Change MRQ vs 1 Year Ago | -126.88% |
| EPS Change (Trailing Twelve Months) | -77.88% |
| EPS Growth (3 Year) | 14.53% |
| EPS Growth (5 Year) | 1.60% |
| EBITDA | |
| EBITDA (5 Year) | 13.68% |
| EBITDA (5 Year Interim) | -12.68% |
| Net Profit Margin | |
| Net Profit Margin Growth (5 Year) | -3.59% |
| Valuation | |
|---|---|
| Total Price to Book | |
| Price to Tangible Book (Last Fiscal Year) | 1 |
| Price to Tangible Book (Most Recent Quarter) | 1 |
| Price to Free Cash Flow | |
| Price to Free Cash Per Share (Last Fiscal Year) | 3 |
| Price to Free Cash Per Share (Trailing Twelve Months) | 11 |
| Net Debt | |
| Net Debt (Most Recent Quarter) | -163,505,000 |
| Net Debt (Last Fiscal Year) | -150,041,000 |
| Price to Sales | |
| Price to Sales (Last Fiscal Year) | 0 |
| Price to Sales (Trailing Twelve Months) | 0 |
| Price to Earnings | |
| PE Excluding Extraordinary Items (Last Fiscal Year) | 7 |
| PE Normalized (Last Fiscal Year) | 2 |
| PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | 8 |
| PE Excluding Extraordinary Items High (Trailing Twelve Months) | 23 |
| PE Excluding Extraordinary Items Low (Trailing Twelve Months) | 6 |
| PE Including Extraordinary Items (Trailing Twelve Months) | 7 |
| Dividends | |
| Dividend Yield (5 Year) | 3.59% |
| Dividend Yield | -99,999.99% |
| Current Dividend Yield | 9.02% |
| Price to Book | |
| Price to Book (Last Fiscal Year) | 1 |
| Price to Book (Most Recent Quarter) | 1 |
| Financial Strength | |
|---|---|
| Debt to Equity | |
| Long Term Debt to Equity (Last Fiscal Year) | 0 |
| Long Term Debt to Equity (Most Recent Quarter) | 0 |
| Payout Ratio | |
| Payout Ratio (Last Fiscal Year) | 54.94% |
| Payout Ratio (Trailing Twelve Months) | 62.75% |
| Quick Ratio | |
| Quick Ratio (Last Fiscal Year) | 2 |
| Quick Ratio (Most Recent Quarter) | 2 |
| Enterprise Value | |
| Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | 2 |
| Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | -100,000 |
| Current Ratio | |
| Current Ratio (Last Fiscal Year) | 2 |
| Current Ratio (Most Recent Quarter) | 3 |
| Free Cash Flow | |
| Free Cash Flow (Last Fiscal Year) | 68.2M |
| Free Cash Flow (Trailing Twelve Months) | 17.7M |
| Net Interest Coverage | |
| Net Interest Coverage (Last Fiscal Year) | -100,000 |
| Net Interest Coverage (Trailing Twelve Months) | -100,000 |
| Total Debt to Equity | |
| Total Debt to Equity (Last Fiscal Year) | 0 |
| Total Debt to Equity (Most Recent Quarter) | 0 |
| Management Effectiveness | |
|---|---|
| Return on Assets | |
| Return on Assets (Last Fiscal Year) | 31.76% |
| Return on Assets (Trailing Twelve Months) | 9.58% |
| Return on Assets (5 Year) | 41.25% |
| Return on Equity | |
| Return on Equity (Last Fiscal Year) | 55.77% |
| Return on Equity (Trailing Twelve Months) | 15.01% |
| Return on Equity (5 Year) | 75.85% |
| Return on Investment | |
| Return on Investment (Last Fiscal Year) | 50.60% |
| Return on Investment (Trailing Twelve Months) | 13.89% |
| Return on Investment (5 Year) | 69.38% |